Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy - PubMed (original) (raw)
Identification of a nucleoside/nucleobase transporter from Plasmodium falciparum, a novel target for anti-malarial chemotherapy
M D Parker et al. Biochem J. 2000.
Abstract
Plasmodium, the aetiologic agent of malaria, cannot synthesize purines de novo, and hence depends upon salvage from the host. Here we describe the molecular cloning and functional expression in Xenopus oocytes of the first purine transporter to be identified in this parasite. This 422-residue protein, which we designate PfENT1, is predicted to contain 11 membrane-spanning segments and is a distantly related member of the widely distributed eukaryotic protein family the equilibrative nucleoside transporters (ENTs). However, it differs profoundly at the sequence and functional levels from its homologous counterparts in the human host. The parasite protein exhibits a broad substrate specificity for natural nucleosides, but transports the purine nucleoside adenosine with a considerably higher apparent affinity (K(m) 0.32+/-0.05 mM) than the pyrimidine nucleoside uridine (K(m) 3.5+/-1.1 mM). It also efficiently transports nucleobases such as adenine (K(m) 0.32+/-0.10 mM) and hypoxanthine (K(m) 0.41+/-0.1 mM), and anti-viral 3'-deoxynucleoside analogues. Moreover, it is not sensitive to classical inhibitors of mammalian ENTs, including NBMPR [6-[(4-nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine, or nitrobenzylthioinosine] and the coronary vasoactive drugs, dipyridamole, dilazep and draflazine. These unique properties suggest that PfENT1 might be a viable target for the development of novel anti-malarial drugs.
Similar articles
- Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R, Frame IJ, Sosa Y, Akabas MH. Deniskin R, et al. Int J Parasitol Drugs Drug Resist. 2015 Nov 28;6(1):1-11. doi: 10.1016/j.ijpddr.2015.11.003. eCollection 2016 Apr. Int J Parasitol Drugs Drug Resist. 2015. PMID: 26862473 Free PMC article. - Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta.
Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, Baldwin SA. Griffiths M, et al. Biochem J. 1997 Dec 15;328 ( Pt 3)(Pt 3):739-43. doi: 10.1042/bj3280739. Biochem J. 1997. PMID: 9396714 Free PMC article. - Purine import into malaria parasites as a target for antimalarial drug development.
Frame IJ, Deniskin R, Arora A, Akabas MH. Frame IJ, et al. Ann N Y Acad Sci. 2015 Apr;1342(1):19-28. doi: 10.1111/nyas.12568. Epub 2014 Nov 25. Ann N Y Acad Sci. 2015. PMID: 25424653 Free PMC article. Review. - Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins.
Young JD, Yao SY, Sun L, Cass CE, Baldwin SA. Young JD, et al. Xenobiotica. 2008 Jul;38(7-8):995-1021. doi: 10.1080/00498250801927427. Xenobiotica. 2008. PMID: 18668437 Review.
Cited by
- Substrate and Inhibitor Specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1.
Arora A, Deniskin R, Sosa Y, Nishtala SN, Henrich PP, Kumar TR, Fidock DA, Akabas MH. Arora A, et al. Mol Pharmacol. 2016 Jun;89(6):678-85. doi: 10.1124/mol.115.101386. Epub 2016 Apr 5. Mol Pharmacol. 2016. PMID: 27048953 Free PMC article. - The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum.
Martin RE, Henry RI, Abbey JL, Clements JD, Kirk K. Martin RE, et al. Genome Biol. 2005;6(3):R26. doi: 10.1186/gb-2005-6-3-r26. Epub 2005 Mar 2. Genome Biol. 2005. PMID: 15774027 Free PMC article. - Accessibility of substituted cysteines in TM2 and TM10 transmembrane segments in the Plasmodium falciparum equilibrative nucleoside transporter PfENT1.
Nishtala SN, Arora A, Reyes J, Akabas MH. Nishtala SN, et al. J Biol Chem. 2019 Feb 8;294(6):1924-1935. doi: 10.1074/jbc.RA118.006547. Epub 2018 Dec 12. J Biol Chem. 2019. PMID: 30541922 Free PMC article. - Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.
Huthmacher C, Hoppe A, Bulik S, Holzhütter HG. Huthmacher C, et al. BMC Syst Biol. 2010 Aug 31;4:120. doi: 10.1186/1752-0509-4-120. BMC Syst Biol. 2010. PMID: 20807400 Free PMC article.
References
- Eur J Haematol. 1992 Aug;49(2):71-6 - PubMed
- Neuron. 1992 Nov;9(5):861-71 - PubMed
- J Biol Chem. 1999 Dec 3;274(49):35255-61 - PubMed
- Mol Med Today. 1999 May;5(5):216-24 - PubMed
- J Biol Chem. 1988 Sep 5;263(25):12391-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources